Dawn K. Slifka - Concepedia

Author

Dawn K. Slifka

Also Known As

Dawn K. Slifka, Mark K Slifka, Slifka, Mark K

Publications

Citations

H-Index

Concepts

All Affiliations

Dawn K. Slifka is an author at Najít Technologies (United States) specializing in vaccine development, vaccination, and infection control.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	21
2	Immunology	1	1	21
3	Vaccine Development	1	1	21
4	Infection Control	1	1	21
5	Vaccination	1	1	21

Dawn K. Slifka

Publications

Citations

H-Index

Page 1

	Year	Citations
An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adults Christopher W. Woods, Ana M. Sánchez, Geeta K. Swamy, Vaccine	2019	31
Pre-clinical development of a hydrogen peroxide-inactivated West Nile virus vaccine Elizabeth A. Poore, Dawn K. Slifka, Hans-Peter Raué, Vaccine VaccinationVaccine DevelopmentVaccine TargetImmunologyVirology	2016	21
Development of a next-generation chikungunya virus vaccine based on the HydroVax platform Dawn K. Slifka, Hans-Peter Raué, Whitney C. Weber, PLoS Pathogens	2022	19

Page 1